Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.5100
+0.0497 (10.80%)
At close: Dec 5, 2025, 4:00 PM EST
0.5098
-0.0002 (-0.04%)
After-hours: Dec 5, 2025, 7:59 PM EST
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $30.63 million as of December 5, 2025. Its market cap has decreased by -26.37% in one year.
Market Cap
30.63M
Enterprise Value
23.68M
1-Year Change
-26.37%
Ranking
Category
Stock Price
$0.51
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $30.63M, a decrease of -53.60%. That is a compound annual growth rate of -27.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 30.63M | 15.23% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |